614 related articles for article (PubMed ID: 8630596)
1. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
3. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy.
Scher H; Berman D; Weinberg EG; Schinkel M; Peper B; Chalton DO; Potter PC
Clin Exp Allergy; 1996 Oct; 26(10):1131-41. PubMed ID: 8911698
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication.
Venge P; Dahl R; Peterson CG
Int Arch Allergy Appl Immunol; 1988; 87(3):306-12. PubMed ID: 3144513
[TBL] [Abstract][Full Text] [Related]
6. Serum eosinophil cationic protein (ECP) as a mediator of inflammation in acute asthma, during resolution and during the monitoring of stable asthmatic patients treated with inhaled steroids according to a dose reduction schedule.
Kunkel G; Rydén AC
Inflamm Res; 1999 Feb; 48(2):94-100. PubMed ID: 10202995
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics.
Dal Negro R; Micheletto C; Tognella S; Mauroner L; Burti E; Turco P; Pomari C; Cantini L
J Investig Allergol Clin Immunol; 1999; 9(4):241-7. PubMed ID: 10513351
[TBL] [Abstract][Full Text] [Related]
8. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
9. Effect of budesonide on the perception of induced airway narrowing in subjects with asthma.
Salome CM; Reddel HK; Ware SI; Roberts AM; Jenkins CR; Marks GB; Woolcock AJ
Am J Respir Crit Care Med; 2002 Jan; 165(1):15-21. PubMed ID: 11779724
[TBL] [Abstract][Full Text] [Related]
10. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
[TBL] [Abstract][Full Text] [Related]
11. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
[TBL] [Abstract][Full Text] [Related]
12. Potential masking effects of salmeterol on airway inflammation in asthma.
Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children.
Sorva R; Metso T; Turpeinen M; Juntunen-Backman K; Björksten F; Haahtela T
Pediatr Allergy Immunol; 1997 Feb; 8(1):45-50. PubMed ID: 9260219
[TBL] [Abstract][Full Text] [Related]
14. Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects.
Kuo HP; Yu TR; Yu CT
Eur Respir J; 1994 Aug; 7(8):1452-9. PubMed ID: 7957830
[TBL] [Abstract][Full Text] [Related]
15. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.
Wever AM; Wever-Hess J; Hermans J
Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings VM; Jatakanon A; Worsdell YM; Barnes PJ
Am J Respir Crit Care Med; 1997 Feb; 155(2):542-8. PubMed ID: 9032192
[TBL] [Abstract][Full Text] [Related]
17. Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease.
Dahlén I; Janson C; Björnsson E; Stålenheim G; Peterson CG; Venge P
Respir Med; 2001 Nov; 95(11):891-7. PubMed ID: 11716203
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil activity in bronchial asthma.
Venge P
Allergy Proc; 1994; 15(3):139-41. PubMed ID: 7926713
[TBL] [Abstract][Full Text] [Related]
19. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.
Pizzichini E; Pizzichini MM; Efthimiadis A; Evans S; Morris MM; Squillace D; Gleich GJ; Dolovich J; Hargreave FE
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):308-17. PubMed ID: 8756799
[TBL] [Abstract][Full Text] [Related]
20. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment.
Kristjánsson S; Strannegård IL; Strannegård O; Peterson C; Enander I; Wennergren G
J Allergy Clin Immunol; 1996 Jun; 97(6):1179-87. PubMed ID: 8648010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
